• Shattuck Labs Inc STTK.OQ reported a quarterly adjusted loss of 37 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of -41 cents. The mean expectation of five analysts for the quarter was for a loss of 32 cents per share. Wall Street expected results to range from -46 cents to -24 cents per share.

• Reported revenue was zero​; analysts expected $799.40 thousand.

• Shattuck Labs Inc's reported EPS for the quarter was a loss of 37 cents​.

• The company reported a quarterly loss of $18.68 million.

• Shattuck Labs Inc shares had fallen by 2.5% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 1.5% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy"

• Wall Street's median 12-month price target for Shattuck Labs Inc is $2.60

This summary was machine generated from LSEG data March 27 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)